Fulltext present in this item

Thumbnail
Fulltext: 197395.pdf
Format: PDF
Description: publisher's version
Title: A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women
Author(s): Schalkwijk, S.J.; Heine, R. ter; Colbers, A. ; Huitema, Alwin D.R.; Denti, Paolo; Dooley, Kelly E.; Greupink, R.; Russel, F.G.M. ; Mirochnick, Mark; Burger, D.M.
Publication year: 2018
Source: Clinical Pharmacokinetics, vol. 57, iss. 11, (2018), pp. 1421-1433
ISSN: 0312-5963
DOI: https://doi.org/10.1007/s40262-018-0642-9
Publication type: Article / Letter to editor

Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/197395   https://hdl.handle.net/2066/197395

Display more details
Subject: All institutes and research themes of the Radboud University Medical Center
Radboudumc 11: Renal disorders RIMLS: Radboud Institute for Molecular Life Sciences
Radboudumc 4: lnfectious Diseases and Global Health RIHS: Radboud Institute for Health Sciences
Organization: Pharmacology-Toxicology
Clinical Pharmacy
IMM - Institute for Molecules and Materials
Journal title:
Clinical Pharmacokinetics
Volume: vol. 57
Issue: iss. 11
Page start: p. 1421
Page end: p. 1433

This item appears in the following Collection(s)

Browse

Statistics